Lanxess Reports Record Third Quarter, Confirms Guidance, Acquires Biocides Business in the U.S.
09:20 AM | November 10, 2011 | Natasha Alperowicz
Lanxess today reported a 31% increase in third quarter net profits to €154 million ($210 million) on 26% higher sales at €2.3 billion, compared with the year-earlier period. Earnings per share were 30...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.